A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells

PD-1-targeted therapies have shown modest antiviral effects in preclinical models of chronic viral infection. Thus, novel therapy protocols are necessary to enhance T cell immunity and viral control to overcome T cell dysfunction and immunosuppression. Here, we demonstrate that nanoparticle-based th...

Descripción completa

Detalles Bibliográficos
Autores principales: Knuschke, Torben, Kollenda, Sebastian, Wenzek, Christina, Zelinskyy, Gennadiy, Steinbach, Philine, Dittmer, Ulf, Buer, Jan, Epple, Matthias, Westendorf, Astrid M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858051/
https://www.ncbi.nlm.nih.gov/pubmed/33531395
http://dx.doi.org/10.1128/mBio.02121-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858051/
https://www.ncbi.nlm.nih.gov/pubmed/33531395
http://dx.doi.org/10.1128/mBio.02121-20

Ejemplares similares